Buyers from China proceed to indicate distinctive curiosity in younger life science firms primarily based in Europe.

Investments made by Chinese language VCs have considerably grown 17-fold during the last 5 years (from EUR 34m in 2017 to EUR 592m in 2021).

The highest investor have been Morningside Group investing EUR 225m in fourteen offers, adopted by Tencent Holdings (EUR 194m) in seven offers and the Ally Bridge Group (EUR 92m) in three offers.

The noticed pattern signifies growing curiosity in European healthcare applied sciences by Chinese language VCs.

Leave a Reply

Your email address will not be published.